Mode
Text Size
Log in / Sign up

n-acetylcysteine

4 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of n-acetylcysteine

39 trials tracked of n-acetylcysteine: 6 in phase 3 or 4 and 2 with published results. The most-cited published study has 501 citations.

39Trials tracked
6Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 4 2 Phase 3 4 Phase 2 27 Phase 1 4 Other / NA 2
  1. Phase 3 Prevention of Serious Adverse Events Following Angiography Completed · 501 cited
  2. Phase 3 Achieving Cannabis Cessation-Evaluating N-Acetylcysteine Treatment Completed · 153 cited
  3. Phase 4 Effects of N-acetylcysteine on Cardiorespiratory Control in COPD Patients With Mild-to-moderate Airflow Obstruction Completed
  4. Phase 4 Effects of N-acetylcysteine on Low T3 Syndrome Completed
  5. Phase 3 N-acetylcysteine in Non-Acetaminophen Pediatric Acute Liver Failure Completed
  6. Phase 3 A Safety and Efficacy Study of NAC in Patients With TA-TMA Completed
Show 33 more trials
  1. Phase 2 Neurocircuit Strategy to Decrease Cocaine Cue Reactivity Completed
  2. Phase 2 N-Acetyl-Cysteine (NAC) in Early Phase Schizophrenia Spectrum Psychosis Completed
  3. Phase 2 Efficacy and Safety of Rifaximin With NAC in IBS-D Completed
  4. Phase 2 Neuroscience-Informed Treatment Development for Adolescent Alcohol Use Completed
  5. Phase 2 Study to Evaluate the Efficacy of N-acetylcysteine (NAC) in the Treatment of the Common Cold and Cough Completed
  6. Phase 2 N-Acetylcysteine for Adolescent Alcohol Use Disorder Completed
  7. Phase 2 Antioxidant Therapy in RYR1-Related Congenital Myopathy Completed
  8. Phase 2 Safety of N-acetylcysteine in Maternal Chorioamnionitis (NAC in Chorio) Completed
  9. Phase 2 Effectiveness of N-Acetylcysteine (NAC) in Treating Cocaine Dependent Individuals - 1 Completed
  10. Phase 2 A Trial of N-Acetylcysteine (an Over-the-Counter Medicine) in Adolescents Who Smoke Marijuana Completed
  11. Phase 2 A Feasibility Study of N-acetylcysteine for Self-injurious Behavior in Children With Autism Spectrum Disorder Completed
  12. Phase 2 N-Acetylcysteine for Neuroprotection in Parkinson's Disease Completed
  13. Phase 2 N-Acetylcysteine for Pediatric Trichotillomania Completed
  14. Phase 2 Memory and Antioxidants in Vascular Impairment Trial Completed
  15. Phase 2 N-acetylcysteine in the Treatment of PTSD and Addiction Completed
  16. Phase 2 Oral N-acetylcysteine for Protection of Human Nevi Against UV-induced Oxidative Stress/Damage in Vivo Completed
  17. Phase 2 An Open-Label Trial of N-Acetylcysteine in Cannabis Dependent Adolescents Completed
  18. Phase 2 N-acetylcysteine (NAC) for Pediatric Obsessive-Compulsive Disorder Completed
  19. Phase 2 Modulation of Lung Injury Complicating Lung Resection Completed
  20. Phase 2 A Study of Oral N-Acetylcysteine in Children With Autism Spectrum Disorders Completed
  21. Phase 2 Pilot Study of Losartan and N-acetylcysteine as Inhibitors of Muscle Oxidative Stress in Elderly Completed
  22. Phase 2 NAC for Treating Comorbid PTSD and SUD Completed
  23. Phase 2 N-Acetylcysteine in Neonatal Congenital Heart Surgery (INACT Study) Completed
  24. Phase 2 N-acetylcysteine Treatment of Alcohol Use Disorder In Veterans With TBI Completed
  25. Phase 2 N-acetylcysteine in Alcohol Dependence Completed
  26. Phase 2 Imaging GABAergic/Glutamatergic Drugs in Bipolar Alcoholics Alcoholics Completed
  27. Phase 2 A Study to Assess the Safety and Tolerability of N-Acetylcysteine When Administered With Pirfenidone to Participants With Idiopathic Pulmonary Fibrosis (IPF) Completed
  28. Phase 1 n-Acetylcysteine and Cocaine Completed
  29. Phase 1 Hypertrophic Regression With N-Acetylcysteine in HCM Completed
  30. Phase 1 Bioequivalence Study of Two Different Formulations of N-acetyl-cysteine (NAC) Completed
  31. Phase 1 Intravenous N-acetylcysteine for the Treatment of Gaucher's Disease and Parkinson's Disease Completed
  32. N/A Effect of Long-term, High-dose N-acetylcysteine on Exacerbations of Bronchiectaisis Completed
  33. N/A Effect of the Anti-oxidant N-acetylcysteine on Beta-cell Function in Type 2 Diabetes Completed

Showing the 39 most-cited and recently-updated of 39 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.